IDO WOLF

Prof. Wolf completed his B. Med. Sc. and M.D. studies at the Faculty of Health Science, Ben Gurion University of the Negev and specialized in internal medicine and medical oncology at the Sheba Medical Center. He completed his MA at the Sackler Faculty of Medicine, Tel Aviv University and did a postdoctoral fellowship at the Division of Hematology Oncology, Cedar-Sinai Medical Center, UCLA School of Medicine under the supervision of Prof. HP Koeffler. Prof. Wolf was former head of the Oncology Department at Sheba Medical Center and currently heads the Oncology Division of Tel Aviv Medical Center. He also Heads the Oncology Research Lab at Tel Aviv Medical Center. His research focuses on endocrine aspects of gastrointestinal cancers. His team discovered the tumor suppressor activities of the hormone klotho and was among the first to identify novel mutations of the estrogen receptor, which confer resistance to hormonal therapies. Current projects in the lab focus on the role of genomic alterations in gastrointestinal malignancies determining tropism of metastases. He published over 60 peer-reviewed articles and won prestigious grants and awards, including ISF, BSF, ICA and the Hirchberg Pancreatic Cancer Foundation Award.